Scientific Program Committee

Wednesday
February 6 Sessions
Session 40 CROI 2008
c Wednesday, 2-3 pm; Room 311
CME
Session 40–Poster Discussion
(see Session 49 on Tuesday for corresponding Poster Abstracts)
New Insights into APOBEC Proteins
Discussants:
Francois Clavel, Hosp Bichat, Paris, France
Welkin Johnson, New England Primate Res Ctr, Harvard Med Sch, Southborough,
MA, US
229 Deamination in 3D: Intra- and Intersegmental Transfer of
APOBEC3G Cytidine Deaminase
Roni Nowarski*, M Kotler, and E Britan
Hebrew Univ, Hadassah Med Sch, Jerusalem, Israel
230 APOBEC3G’s Cytoplasmic Localization Is Actively
Regulated but Not Required for HIV-1 Restriction
Mark Stenglein* and R Harris
Univ of Minnesota, Minneapolis, US
231 Enzymatically Active APOBEC3G Is Required for Efficient
Inhibition of HIV-1
E Miyagi, S Opi, H Takeuchi, M Khan, R Goila-Gaur, S Kao, and
Klaus Strebel*
NIH, Bethesda, MD, US
232 Distinct Packaging Mechanisms of Human Cytidine
Deaminase APOBEC3 Proteins into HIV-1 Virions
Lindi Tan*, T Wang, and X Yu
Johns Hopkins Univ, Baltimore, MD, US
233 Effect of Impaired Processivity of HIV-1 Reverse
Transcriptase on the G-to-A Mutation Rate Induced by
APOBEC-3G/-3F
Stefanie Knoepfel*, P Rauch, N Salisch, K Allers, P Huelsmann, and
K Metzner
Univ of Erlangen-Nuremberg, Germany
234 Protein Kinase A-mediated Phophorylation of APOBEC3G
Antagonizes Its Degradation by Vif
Kotaro Shirakawa*, A Takaori-Kondo, T Izumi, K Io, M Matsui, and
T Uchiyama
Kyoto Univ, Japan
22 15th Conference on Retroviruses and Opportunistic Infections
c Wednesday, 2-3 pm; Room 312
CME
Session 41–Poster Discussion
(see Session 84 on Monday for corresponding Poster Abstracts)
Molecular Epidemiology: The Americas
Discussants:
Beatrice Hahn, Univ of Alabama at Birmingham, US
Andrew Leigh Brown, Univ of Edinburgh, Scotland
505 HIV-1 Transmission Dynamics in Quebec in the HAART Era
Bluma Brenner* 1 , M Roger 2 , D Moisi 1 , J Cox 3 , JP Routy 1 , M Wainberg 1 , and
Quebec PHI Study Group
1 McGill AIDS Ctr, Jewish Gen Hosp, Montreal, Canada; 2 Ctr Hosp Univ
Montreal, Canada; and 3 Quebec Agency of Publ Hlth and Social Svcs,
Canada
506 Tracking Molecular Epidemiology of HIV-1 in Mexico:
Emergence of BG Intersubtype Recombinant
Eduardo Vazquez-Valls* 1 , M Escoto-Delgadillo 1 , R Carabez-Hernandez 2 ,
and B Torres-Mendoza 2
1 UMAE Specialties Hosp, Western Biomed Res Ctr, Mexican Inst of Social
Security, Guadalajara and 2 Univ Hlth Sci Ctr, Univ of Guadalajara,
Mexico
507 Evolutionary Dynamics of HIV-1 BF and CB Recombinants
in South America
Elcio Leal* 1 , L Martins 2 , M Janini 1 , and R Diaz 1
1 Federal Univ of Sao Paulo, Brazil and 2 Grad Sch of Agriculture and Life
Sci, Univ of Tokyo, Japan
508 A Foothold for Subtype C in the Americas: Risk Factors
Associated with Subtype C and Non-Subtype C HIV
Infection among HIV Testing Clients in South Brazil
Oliver Bacon* 1 , R da Silva de Souza 2 , K Page Shafer 1 , R Diaz 3 , V Debastiani 4 ,
G Preussler 5 , M Leticia Ikeda 6 , N Barcellos 7 , W Steward 1 , and C Pilcher 1
1 Univ of California, San Francisco, US; 2 Univ de Caxias do Sul, Rio
Grande, Brazil; 3 Paulista Sch of Med, Federal Univ of Sao Paulo, Brazil;
4 Ambulatorio de DST/AIDS, Caxias do Sul, Rio Grande do Sul, Brazil;
5 Svc de Assistencia Especializado, Ctr de Saude Vila dos Comercarios,
Rio Grande do Sul, Brazil; 6 Svc Especializado de DST/AIDS Herbert de
Souza, Rio Grande do Sul, Brazil; and 7 Hosp Sanatorio Partenon, Rio
Grande do Sul, Brazil
509 Timing the Introduction of HIV-1 Subtype C in Brazil
Gonzalo Bello*, R Lorete, M Guimaraes, C Bittencourt Passaes, and
M Morgado
Oswaldo Cruz Inst, Fiocruz, Rio de Janeiro, Brazil